TrueBinding Highlights the Potential of TB006's Unique Mechanism of Action as a Novel Approach for the Treatment of Alzheimer's Disease at the 15th Clinical Trials on Alzheimer's Disease (CTAD) Conference, Business News
TrueBinding Highlights the Potential of TB006’s Unique Mechanism of Action as a Novel Approach for the Treatment of Alzheimer’s Disease at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference GlobeNewswire December 06, 2022 Novel antibody, TB006, demonstrated improvements in cognition and function and was well tolerated in a one-month Phase 1b/2...
Source: asiaone.com